Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice. [electronic resource]
Producer: 20200622Description: 615-626 p. digitalISSN:- 1365-2141
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Asthenia -- chemically induced
- Biomarkers, Tumor -- genetics
- Drug Eruptions -- etiology
- Female
- Follow-Up Studies
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Prospective Studies
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pruritus -- chemically induced
- Psychometrics
- Pyrimidines -- adverse effects
- Quality of Life
- Treatment Outcome
- Young Adult
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.